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Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and
fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an
important step toward integratingWGS into precisionmedicine.We developed a software tool called ExpansionHunter that,
using PCR-freeWGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than
the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of
the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter cor-
rectly classified all (212/212, 95%CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions
(4). Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type
by this method with the remaining three samples identified as possible expansions. We further applied our algorithm to a set
of 152 samples in which every sample had one of eight different pathogenic repeat expansions, including those associated
with fragile X syndrome, Friedreich’s ataxia, and Huntington’s disease, and correctly flagged all but one of the known repeat
expansions. Thus, ExpansionHunter can be used to accurately detect known pathogenic repeat expansions and provides re-
searchers with a tool that can be used to identify new pathogenic repeat expansions.
[Supplemental material is available for this article.]
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Variant callers for small variants such as single-nucleotide poly-
morphisms and small insertions or deletions typically requiremul-
tiple reads to completely span the full length of the nonreference
allele (DePristo et al. 2011; Raczy et al. 2013). For variants that
deviate significantly from the reference, alternative methods
such as de novo assembly can be used if the variant is not highly
repetitive (Iqbal et al. 2012; Weisenfeld et al. 2014; Li 2015;
Chen et al. 2016). Because high-throughput WGS technologies
are currently limited to ∼150 base pair (bp) read lengths, variant-
callingmethods that rely on reads aligned to the reference are sub-
sequently limited to repeat lengths less than 150 bases (Narzisi and
Schatz 2015). Many pathogenic repeat expansions have repeats
spanning hundreds to thousands of base pairs (Dürr et al. 1996;
Gatchel and Zoghbi 2005; Kronquist et al. 2008; Gijselinck et al.
2016), so it has been assumed that short-read sequencing technol-
ogies may not be able to identify pathogenic repeat expansions
(Loomis et al. 2013; Ashley 2016).
A recently discovered hexamer (GGCCCC) repeat expansion
in theC9orf72 locus is amajor cause of both ALS and frontotempo-
ral dementia (DeJesus-Hernandez et al. 2011; Renton et al. 2011;
Gijselinck et al. 2012). In particular, the pathogenic repeat length
(more than 30 repeats; >180 bp) is present in ∼10% of all ALS pa-
tients including∼40% of familial ALS cases and ∼6%–8% of spora-
dic ALS cases in some populations (DeJesus-Hernandez et al. 2011;
Renton et al. 2011; Gijselinck et al. 2012). The most widely used
method to detect C9orf72 repeat expansions is repeat-primed
PCR (RP-PCR) together with fragment length analysis (Akimoto
et al. 2014). Interpretation of these PCR results can be challenging
due to indels in the flanking regions of the repeat, which can lead
to both false positives and false negatives (Akimoto et al. 2014). In
addition, these PCR techniques do not provide an estimate of the
length of the repeat expansions. Southern blotting is the current
gold standard for estimating repeat length, but this method is
very challenging to set up; requiring a significant amount of input
DNA (generally 10 μg) and suffering from imprecise size estimates
due to somatic heterogeneity (Buchman et al. 2013; Akimoto et al.
2014). AsWGS is widely adopted for use in precisionmedicine ini-
tiatives (Ashley 2015, 2016; Marx 2015) and large-scale research
projects, a reliablemethod is needed that can identify the presence
or absence of potentially pathogenic repeat expansions in WGS
data and also determine their approximate length without addi-
tional tests.
Here, we present a method to genotype STRs from PCR-
free, WGS data implemented in a software package named
ExpansionHunter. This method can determine the approximate
size of repeats from just a few units in length up to large, pathogen-
ic expansions that may be significantly longer than the read
length. To quantify the performance of this algorithm, we first es-
timate the repeat lengths of two cohorts of ALS patients, all of
whom were independently assessed for the presence of the patho-
genic C9orf72 repeat expansion using RP-PCR, and determine the
overall sensitivity and specificity of the assay. In addition, we also
demonstrate that this method is generally applicable for detecting
other repeat expansions by applying it to a set of 152 samples har-
boring eight other repeat expansions including those that cause
fragile X syndrome, Friedreich’s ataxia, and Huntington’s disease.
We also demonstrate the improved accuracy of this method for
genotyping STRs shorter than the read length compared to an ex-
isting method (lobSTR) on 860 samples for which the size of the
longest repeat allele had been experimentally determined. These
analyses show that ExpansionHunter is a comprehensive tool for
genotyping both short and long repeats. Thus, it can be used to
test for the presence of known pathogenic repeat expansions and
can be extended as a general STR caller to identify novel pathogen-
ic expansions in population and pedigree studies.
Results
We performed paired-end, PCR-free, WGS at an average depth of
45× using Illumina HiSeq 2000 (100 bp reads) and Illumina
HiSeq X (150 bp reads) systems on two cohorts of patients with
ALS (Methods). The first cohort of 2559 patients was used during
the development of ExpansionHunter to test the implementation
of the algorithm for bugs and to calculate off-target regions (al-
though the core algorithm and its parameters were not informed
by these data). The second cohort of 442 patients was used to val-
idate the implementation of the program. All 3001 samples were
tested for presence of the C9orf72 repeat expansion with RP-PCR
(Methods). A second RP-PCR test using a different primer set, frag-
ment length analysis, and Southern blotting was performed on 71
samples from the initial cohort, of which 55 had a pathogenic
C9orf72 repeat according to the first RP-PCR (Supplemental
Table 2). Additionally, the fluorescent PCR plots were reevaluated
for a subset of the samples (Supplemental Fig. 6). As explained in
the section on pathogenic C9orf72 repeat expansion determina-
tion, some of the original RP-PCR calls were deemed incorrect
based on this reassessment and changed accordingly (Supplemen-
tal Table 2), bringing the total counts of expanded and wild-type
samples to 212 and 2789, respectively.
To quantify repeat lengths, we developed an algorithm that
identifies reads that either (1) fully span the repeat (spanning
reads); or (2) include the repeat and the flanking sequence on
one side of the repeat (flanking reads); or (3) are fully contained
in the repeat (“in-repeat” reads or IRRs) (Fig. 1). For repeats shorter
than the read length of the sequence data we calculate the repeat
length using spanning and flanking reads (Fig. 1). To estimate the
lengths of repeats that are longer than the read length, we identify
and count the IRRs. There are three main hurdles associated with
using IRRs to accurately identify repeat expansions that exceed
read lengths: (1) identifying IRRs comprised of a potentially error-
prone repeat motif; (2) identifying regions in the genome where
paired IRRs are systematically (and possibly incorrectly) placed by
the aligner; and (3) estimating the repeat length based on the total
number of IRRs identified. Here, we describe how we solve these
problems to identify and characterize expanded repeats accurately.
On-target IRRs
Identifying reads originating in highly repetitive regions can be
difficult because sequencing error rates are higher in low complex-
ity regions such as homopolymers and STRs (Benjamini and Speed
2012), so we implemented a weighted measure that penalizes base
mismatches at low-quality bases less than mismatches at high-
quality bases (Methods). To identify IRRs that originate within
the C9orf72 repeat, we extracted all read pairs in which one read
is an IRR and the other read aligns with high accuracy (mapping
quality [MAPQ] at least 60) within 1 kbp of the C9orf72 repeat lo-
cus. We call such reads anchored IRRs. Because the mates of an-
chored IRRs align uniquely near the target repeat, we are
confident that the IRRs come from the C9orf72 repeat locus.
Anchored IRRs can be used to estimate the size of repeats that
are longer than the read length but shorter than the fragment
length. For repeats exceeding the fragment length, the number
of anchored IRRs provides a lower bound for the repeat length.
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Off-target IRRs
The library preparation used for these sequencing experiments had
a mean fragment size of ∼350–450 bp, but the C9orf72 repeat ex-
pansion can be >10 kbp in length (Gijselinck et al. 2016). This
means that in addition to anchored IRRs, pairs in which both ma-
tes are IRRs could be present in samples with theC9orf72 repeat ex-
pansion (Fig. 1). Because the expanded repeat is not present in the
reference, these paired IRRsmay not align to theC9orf72 repeat lo-
cus and could either not align at all or misalign to a different locus
in the genome (Church et al. 2015; Gijselinck et al. 2016). To iden-
tify unaligned ormisaligned IRRs, we tested every (MAPQ= 0) read
in all 182 expanded ALS samples of the first cohort identified by
the first round of RP-PCR as having the C9orf72 repeat expansion.
These 182 samples contained 29,619 poorly mapped paired IRRs
altogether—33% of these were unaligned and 67% resided in 29
loci (whichwe termoff-target regions), and only 0.1%were located
elsewhere (Methods). Conversely, when we performed the same
analysis on 182 random samples without the C9orf72 repeat ex-
pansion according to RP-PCR, we did not find paired IRRs in any
genomic locus.
We next analyzed positions where the mates of anchored
IRRs aligned in all 2559 samples from cohort one. For each sample,
we identified all the anchored IRRs and
then grouped the IRRs anchored within
500 bp of one another. The C9orf72 re-
peat locus had many anchored IRRs in
nearly all samples with a pathogenic re-
peat expansion (178 samples had five
or more anchored IRRs and 160 had 10
or more) indicating that the repeat ex-
ceeds the read length in these samples
as expected. Only 10 genomic loci had
more than one IRR anchored outside of
the C9orf72 repeat locus in any of these
samples (Fig. 2). Based on this, we con-
sidered all paired IRRs to originate from
the C9orf72 repeat locus and included
them in the size estimation when testing
this repeat.
Repeat size estimation
Improvements to short-read sequencing
technology such as PCR-free sample
preparation minimize the GC bias that
previously bedeviled PCR-based WGS
data (Meienberg et al. 2016). This is illus-
trated by the improved coverage of high
GC regions such as the FMR1 repeat
(Supplemental Fig. 5). These improve-
ments enabled us to estimate the length
of a region by the number of reads that
originate from it even for regions with
high GC content. By assuming that the
number of reads that originate in a given
region follows a binomial distribution,
wewere able to estimate the size of the re-
peat by the number of IRRs. The number
of IRRs in individual samples ranged
from 0 to 1314 corresponding to estimat-
ed C9orf72 repeat sizes of up to 7152 bp.
For shorter alleles, the sizes of re-
peats were determined using spanning
reads (Fig. 1). For repeats that are close to the read length, the re-
peat may be too long to produce spanning reads but too short to
produce IRRs. Therefore, the algorithm also uses flanking reads
(Fig. 1) to estimate the repeat size (Methods). In the 2559 samples
of cohort one, 1.6% (40) of the samples had a repeat size estimated
using only flanking reads that resulted in repeat size estimates from
18 to 144 bp (Supplemental Table 2).
ExpansionHunter computes the maximum-likelihood geno-
type consisting of candidate repeat alleles determined by span-
ning, flanking, and in-repeat reads (Methods). When both alleles
are longer than the read length, the algorithm computes intervals
for possible sizes of short and long repeats based on the two ex-
treme cases: (1) All reads come from one haplotype; or (2) half
the reads come from each haplotype.
Pathogenic C9orf72 repeat expansion detection
The C9orf72 repeat sizes for both ALS cohorts determined by our
method were compared to the RP-PCR results (Supplemental
Table 2). Cases in which the estimated confidence interval for re-
peat size overlapped the pathogenic C9orf72 repeat size cutoff
(i.e., the lower bound was less than 30 repeats and the upper
bound was greater than 30 repeats) were defined as “gray” and
Figure 1. An outline of how ExpansionHunter catalogs reads associated with the repeat locus of inter-
est and estimates repeat lengths starting from a binary alignment/map (BAM) file. (Left) Exact sizes of
short repeats are identified from spanning reads that completely contain the repeat sequence.
(Middle) When the repeat length is close to the read length, the size of the repeat is approximated
from the flanking reads that partially overlap the repeat and one of the repeat flanks. (Right) If the repeat
is longer than the read length, its size is estimated from reads completely contained inside the repeat (in-
repeat reads). In-repeat reads anchored by their mate to the repeat region are used to estimate the size of
the repeat up to the fragment length. When there is no evidence of long repeats with the same repeat
motif elsewhere in the genome, pairs of in-repeat reads can also be used to estimate the size of long
(greater-than-fragment-length) repeats.
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one for the genomic loci with at least two anchored IRRs in at least one sample (Methods).
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considered “long” in all sensitivity/specificity calculations. Using
the original RP-PCR calls as the ground truth, we identified 11
discrepant calls between our method and RP-PCR, resulting in
the overall sensitivity and specificity of 98.6% and 99.6%, respec-
tively, for the WGS-based calls. Because RP-PCR involves many
manual steps and, as has been shown previously, could be prone
to error (Akimoto et al. 2014), we performed an additional anal-
ysis of the discrepant calls to understand the source of these
conflicts.
Of the 11 samples with a discrepant classification between
our method and the RP-PCR calls, eight were “EH positive/RP-
PCR negative” (positive = expansion; negative = normal); howev-
er, each of these discrepant calls had at least 13 anchored IRRs,
which constitutes strong supporting evidence for a pathogenic
repeat expansion in these samples (Supplemental Table 4;
Supplemental Fig. 6). Predicting the repeat length using only
the anchored reads also supported the pathogenic repeat expan-
sion sizing in all eight “EH positive/RP-PCR negative” samples.
Conversely, two of the three “EH negative/RP-PCR positive” sam-
ples had compelling read-level evidence supporting their negative
status: The read-level data supported repeat alleles of two distinct
sizes, each spanning fewer than 30 repeat units. Specifically, one
sample contained 10 spanning reads with a repeat of size 2 and
10 spanning reads with a repeat of size 5, whereas the other sample
had a size estimate just under the pathogenic cutoff (16 to 26 re-
peat units). The final “EH negative/RP-PCR positive” sample had
just one allele identified (consisting of two repeat units), but the
number of spanning reads (38) was consistent with the read depth
(mean depth = 44×) in this sample supporting a homozygous,
nonpathogenic variant (Supplemental Table 4; Supplemental
Fig. 6).
Wealso reevaluated theoriginalRP-PCRcalls for eight samples
(Supplemental Fig. 6) and performed an additional RP-PCR and
fragment length analysis for 71 samples (Supplemental Table 2).
This analysis showed that in 10 of the 11 conflicting calls, the
original RP-PCR call was incorrect; therefore, ExpansionHunter
and the RP-PCR results were consistent (Supplemental Table 4).
The remaining conflict was also resolved after an additional
RP-PCR was performed on this sample with different primers
(Methods). Additionally, one sample classified as gray range by
ExpansionHunter was reclassified from RP-PCR positive to RP-
PCR negative. Fragment length analysis estimated the repeat in
this sample to be between28 and30 repeat units. Becausewe count
gray range samples as expanded, we now consider this sample as
misclassified by our analysis, although the experimental size range
overlaps the size rangepredictedbyExpansionHunter. The remain-
ing67 samples hadno conflicts betweenExpansionHunter andRP-
PCR in either the first or second RP-PCR analysis. Reclassifying the
original calls based on this additional analysis, the total number
RP-PCR expanded samples increased from 208 to 212.
Comparing our calls against the updated RP-PCR results
showed that the only discrepancies in classification are due to
the seven “gray” calls, in which the samples likely have repeat
lengths close to 30 repeat units (Table 1). Because we consider
“gray” calls as expanded, this method produced just three false
positives (EH gray/RP-PCR negative) and no false negatives.
Overall, ExpansionHunter correctly flagged all (212/212, 95% CI
[98.7%, 100%]) of the expanded samples as either expansions
(208) or potential expansions (4). Additionally, 99.9% (2,786/
2,789, 95% CI [99.7%, 100%]) of the nonexpanded samples were
correctly classified, and the three discrepant calls were labeled as
“gray” by ExpansionHunter.
Repeats shorter than the read length
To quantify the accuracy of ourmethod for alleles shorter than the
read length, we compared our results to those obtained on 860
samples for which the size of the longest allelewas estimated using
fragment length analysis (Supplemental Table 2). In addition, we
also analyzed these samples using the STR calling tool lobSTR
(Gymrek et al. 2012). It should be noted that lobSTR is designed
for general genome-wide STR calling based on spanning reads
and is limited to calling repeat lengths shorter than the read
length, so it may notmake a call for longer repeats. In this compar-
ison, the ExpansionHunter calls agreed with the fragment length
analysis in 821 (95.5%) of the samples, and the lobSTR calls agreed
with the fragment length analysis in 734 (85.3%) of the samples.
Of the 39 ExpansionHunter repeat sizes that did not agree with
the fragment length analysis, 20 (51%) were in agreement with
the lobSTR calls, and the remaining 19 calls were predicted to be
longer repeats (spanning eight or more repeat units) where
lobSTR is less likely to make a call (Supplemental Tables 2, 5).
Next, we analyzed the 1770 samples that were sequenced
with 2×150 bp reads to get the distribution of the repeat lengths
identified from spanning reads in the C9orf72 repeat. The distribu-
tion determined by this analysis is very similar to the results ob-
tained in a previous study (van der Zee et al. 2013) that used an
alternative repeat-primed PCR assay and a short tandem repeat
(STR) fragment length assay with flanking primers optimized for
alleles with high GC content (STR-PCR) allowing exact sizing of
Table 1. Sensitivity and specificity of C9orf72 repeat expansion detection by ExpansionHunter (EH) on the ALS samples taking the updated RP-
PCR results as the ground truth
First cohort Second cohort
RP-PCR positive RP-PCR negative RP-PCR positive RP-PCR negative
EH positive 181 0 27 0
EH negative 0 2373 0 413
EH gray 3 2 1 1
Sensitivity 100%
95% CI [98.0, 100]
— 100%
95% CI [87.7, 100]
—
Specificity — 99.9%
95% CI [99.7, 100]
— 99.8%
95% CI [98.7, 100]
EH/RP-PCR positive (negative) category refers to samples classified as having an expanded (nonexpanded) C9orf72 repeat by each method. EH gray
calls have confidence intervals overlapping the pathogenic cutoff (30). Gray calls were considered expanded when calculating sensitivity and specificity.
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normal lengths (Fig. 3). This indicates that we can accurately re-
solve the length of the short repeats. Because of the requirement
for reads to span the STR fully, the maximum repeat size called
by lobSTR is 11 repeats, although 4.2% (145 of 3394) of our alleles
are sized greater than 11 repeats.
Applying ExpansionHunter to other repeat expansions
In addition to the C9orf72 repeat, several other pathogenic repeat
expansions have been identified (McMurray 2010). To demon-
strate the general applicability of our method, we tested eight oth-
er pathogenic repeat loci by sequencing and genotyping 152
samples with known expansions and 26 controls. The sample set
contains 98 Coriell samples (https://catalog.coriell.org) from 64
families with a variety of repeat expansions associated with denta-
torubral-pallidoluysian atrophy (DRPLA, ATN1 gene), fragile X
Syndrome (FXS, FMR1 gene), Friedreich’s ataxia (FRDA, FXN
gene), Huntington’s disease (HD, HTT gene), myotonic dystrophy
type 1 (DM1, DMPK gene), spinocerebellar ataxia type 1 (SCA1,
ATXN1 gene), spinocerebellar ataxia type 3 (SCA3, ATXN3 gene),
and spinal and bulbar muscular atrophy (SBMA, AR gene). In addi-
tion to the Coriell samples, our data include 54 samples with HTT
expansions obtained from a rural fishing village in Venezuela with
the highest concentration of Huntington’s disease in the world
(Wexler et al. 2004). These 54 samples were processed with a dif-
ferent alignment software (Li and Durbin 2009) allowing us to
demonstrate that ExpansionHunter is compatible with other com-
monly used short-read aligners.
Taken together, these 152 samples represent different repeats
with a variety of repeat sizes including normal, premutated, and
fully expanded repeats. Premutated repeats are nonpathogenic re-
peats that are predisposed to become pathogenic/fully expanded
in subsequent generations. Normal/premutation transitions for
the repeats that we target ranged between 87 and 165 bases and
premutation/full expansion transitions ranged between 114 and
600 bases. The repeats in the HTT, ATXN1, and AR genes are short
enough that anchored IRRs alone are sufficient to detect the ex-
pansion. For the expansion in the FMR1 gene, we included off-tar-
get reads using the methodology we developed for the C9orf72
repeat to improve our ability to quantify large repeats. We did
not include off-target locations for the other, potentially long re-
peats because the corresponding motifs (CAG and AAG) are com-
mon enough that we could not resolve which repeat the paired
IRRs originated from.
Figure 4 depicts the sizes of the longer repeat allele deter-
mined by ExpansionHunter. Each of the 152 samples was tested
for eight repeat expansions, one ofwhich is expected to be expand-
ed and the rest wild type. All 24 control sampleswere similarly test-
ed across all eight expansions. Our method identified all repeats
expected to be premutated (orange circles) or fully expanded (red
circles). The categorization was correct for all repeats with an ex-
ception of the FMR1 repeats, in which 15 of 16 repeats were esti-
mated by ExpansionHunter to be premutations instead of full
expansions, and one ATXN1 expanded sample was identified in
the normal range.
Although we correctly identified all but one of the ex-
pansions, therewas one “control” sample showing the FXN expan-
sion and three “control” samples with the FMR1 repeat size at the
low end of the premutation range. Both of these results are unsur-
prising due to the higher carrier frequencies for these two repeats:
The carrier frequency is 1:90 for FXN (Zamba-Papanicolaou et al.
2009) and 1:178 for the FMR1 premutation (Hantash et al.
2011). Additionally, there was one “control” sample showing an
ATXN1 expansion. The final three putative FP samples were iden-
tified in the HTT repeat and include a mother and son who were
both sized at 30 repeats (bottom of the premutation range), and
a third sample with 34 repeats, which is small enough for an indi-
vidual to be unaffected. Visual inspection of the reads supported
the ExpansionHunter calls in these samples.
Although ExpansionHunter is intended for unbiased (e.g.,
PCR-free) sequence data, 12 of the samples studied here were se-
quenced with a PCR step in the sample preparation. These com-
prised nine samples with either a premutation or expansion at
theHTT gene and three controls. These sampleswere correctly clas-
sified for the HTT repeat despite the high GC content of this CAG
repeat (67%). Conversely, in these samples the FMR1 repeat length
could not be assessed for all but one of these samples: Four samples
hadno reads covering the repeat and sevenwere covered very poor-
ly (one to three reads covering the repeat) andproduced excessively
small repeat lengths. For example, these seven samples were all
sized at fewer than 10 repeats, whereas for the other 157 samples
sequenced without PCR, only four samples had alleles shorter
than 20 repeats and the smallest of these spanned 14 repeats.
Discussion
We developed a software tool that can identify pathogenic repeat
expansions from paired-end, PCR-free WGS data. Comparing
against the results obtainedwith awidely
used wet lab protocol for identifying
pathogenic repeat expansions in the
C9orf72 locus, ExpansionHunter was
able to correctly classify all expanded
samples as either expansions (208) or po-
tential expansions (4) and 2786 of the
2789 wild-type samples. Some samples
are classified as potential expansions,
because there is an uncertainty associat-
ed with repeats longer than the read
length. In a clinical setting, such calls
would trigger a follow-up analysis; so all
the expansions were flagged in this
analysis.
We also demonstrated that our
method generalizes to other repeats by
correctly identifying the validated
Figure 3. Distribution of ExpansionHunter and lobSTR allele sizes of the C9orf72 repeat in the 1770
samples with 150 bp reads from cohorts one and two, compared with those of the FTLD cohort of
318 samples from a previous study (van der Zee et al. 2013).
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repeats from 152 samples with eight other pathogenic repeat ex-
pansions. In total, we examined five repeat motifs (CTG, GAA,
CGG, CAG, and GGCCCC) at nine different genomic locations
and demonstrated that ExpansionHunter can detect repeat expan-
sions in a variety of sequence contexts. It is particularly important
that our method works on the very high (100%) GC repeats in
FMR1 (CGG) and C9orf72 (GGCCCC) genes, where both coverage
biases and error rates may be elevated. Comparing our size esti-
mates with Southern blot experiments indicated that our method
may underestimate sizes of some very long repeats, particularly
those in the FMR1 and AR genes (Fig. 4; Supplemental Table 7).
This discrepancy could be due to mosaicism of expanded FMR1 re-
peats (in fact, several of the samples with FMR1 expansions were
identified as mosaic in the Coriell database). In addition to mosa-
icism, other factors such as higher error rates and GC biases may
play a role in causing this method to underestimate the size of
these long repeats. Still, the FMR1 expansions were generally sized
as being longer compared to the FMR1 premutations, indicating
that it may be possible to calibrate the size estimates and account
for errors not related to mosaicism. Future work will concentrate
on quantifying this behavior and improving the size estimates
for these long repeats.
ExpansionHunter is designed for PCR-free WGS data, and
comprehensive detection of large pathogenic repeats is unlikely
to work with whole-exome sequence data because (1) many re-
peats of interest are not exonic; and (2) size estimates for large re-
peats require assumptions about the average number of reads per
base. Additionally, some important repeats, like the repeat in
FMR1 gene that causes fragile X syndrome, are 100% GC and are
underrepresented in sequence data that includes a PCR step during
sample preparation.
If there is no evidence of long repeats with the same repeat
motif elsewhere in the genome (e.g., the GGCCCC repeat in
C9orf72), both anchored and paired IRRs can be utilized to esti-
mate the full length of the repeat. If, on the other hand, multiple
long repeats with the same repeat motif exist, then the size of the
repeat is estimated only from anchored in-repeat reads and so is
capped by the fragment length. Although the off-target reads im-
prove the size estimates produced by
this method, most repeats are classified
as pathogenic much closer to the read
length (e.g., Fig. 4). Because of this, in
most cases the anchored reads are suffi-
cient to identify pathogenic repeats
and, for example, all 212 of the C9orf72
expanded samples were also identified
even when using only the anchored
IRRs to estimate the repeat length.
A major benefit of our tool is that it
enables researchers to screen for all
known repeat expansions using a single
whole-genome sequencing run. As the
throughput of WGS increases and the
cost decreases, WGS may soon become
the basis for frontline tests for repeat ex-
pansions and other genetic disorders.
Theoretically, long reads can also identi-
fy many of the longer repeat expansions
(Loomis et al. 2013), but those technolo-
gies are still too expensive to be routinely
used for whole-genome screening. At the
same time, because the substitution and
indel error rates in these long reads range from 10% to 30%
(Sovic ́ et al. 2016; Bao and Lan 2017), it may be difficult to classify
the repeat confidently when its size is close to the normal-premu-
tation or premutation-expansion boundary cutoffs unless the sam-
ples are sequenced to high depth.
Because repeat expansions may expand from generation
to generation, pathogenic repeats may show little or no linkage
disequilibrium with the surrounding variants. Thus, association
studies based solely on SNPs may be blind to these highly poly-
morphic risk alleles. An important result highlighted in Figures
3 and 4 is that ExpansionHunter is able to size both short and
long repeats. This will allow researchers to quantify repeat lengths
of all STRs genome-wide and discover novel pathogenic repeat ex-
pansions agnostically. Although this method can be used to
quantify every repeat in the genome, ExpansionHunter is a tar-
geted tool that requires an STR to be specified by its reference co-
ordinates and repeat motif. Additional work is ongoing to
develop a genome-wide STR database that ExpansionHunter
can use to target any STR genome-wide. As association studies
based on high-depth WGS data become more widespread, it
will be possible to discover new, previously undetected repeat
expansions by genotyping them across the population with
ExpansionHunter.
Methods
Whole-genome sequencing
Whole-genome shotgun sequencing was performed for all of the
samples analyzed in this study. For 1231 of the ALS samples, we
used TruSeq DNA PCR-free sample preparation with 100 bp
paired-end reads sequenced on Illumina HiSeq 2000 instruments.
The remaining 1770 ALS samples, the 128 Coriell samples, and 42
of the Huntington samples used TruSeq DNA PCR-free sample
preparation with 150 bp paired-end reads sequenced on Illumina
HiSeq X instruments. The final eight samples used TruSeq Nano li-
brary preparation with 150 bp paired reads sequenced on Illumina
HiSeq X instruments.
Figure 4. Sizes of the longer repeat alleles predicted by ExpansionHunter in the 152 samples identified
as having either a premutation or an expansion at loci associated with eight different diseases and 24 ad-
ditional control samples. Circles indicate themost-likely repeat length of the longer allele in base pairs for
a sample identified with a premutation (orange) or expansion (red), and the blue circles show the pre-
dicted repeat lengths for the controls. The controls include samples with measurements showing that
they fall in the “normal” range and samples that have a different repeat expansion. Thus, each sample
will have one circle for each of the eight repeat expansions. The regions are shaded to indicate the normal
ranges (blue), premutation ranges (yellow), and expansion sizes (light red) (McMurray 2010). Additional
information is available in Supplemental Tables 7 and 8.
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C9orf72 PCR
Repeat-primed PCR (RP-PCR) was performed on 50–300 ng gDNA
with 1× FastStart Mix (Roche), 0.9 M Betaine, 5% DMSO, 1 mM
MgCl2, 0.2 mM 7-deaza-dGTP, 0.6–1.3 µM F-primer ([6FAM]
AGTCGCTAGAGGCGAAA(GC)), 0.3–1.3 µM R-primer (TACG
CATCCCAGTTTGAGACGGGGGCCGGGGCCGGGGCC(GGGG)),
0.6–1.3 µM anchor-primer (TACGCATCCCAGTTTGAGACG) in a
total volume of 16–30 µL, with this protocol: 15min 95°C; 2 cycles
1 min 94°C, 1 min 70°C, 3 min 72°C; 3 cycles 1 min 94°C, 1 min
68°C, 3 min 72°C; 4 cycles 1 min 94°C, 1 min 66°C, 3 min 72°C;
5 cycles 1 min 94°C, 1 min 64°C, 3 min 72°C; 6 cycles 1 min
94°C, 1 min 62°C, 3 min 72°C; 7 cycles 1 min 94°C, 1 min 60°C,
3 min 72°C; 8 cycles 1 min 94°C, 1 min 58°C, 3 min 72°C; 5 cycles
1 min 94°C, 1 min 56°C, 3 min 72°C; 10 min 72°C. The PCR prod-
uct was analyzed on an ABI 3730 DNA Analyzer (Applied
Biosystems) with PeakScanner software (v1.0). A characteristic
stutter pattern was considered evidence of a C9orf72 repeat expan-
sion. Fluorescent PCR was performed as previously described
(DeJesus-Hernandez et al. 2011).
Confirmation of C9orf72 RP-PCR results
The presence of a repeat expansion was determined in a blinded
fashion using a two-step PCR protocol (DeJesus-Hernandez et al.
2011). Genomic DNA was PCR amplified with genotyping
primers and one fluorescently labeled primer, followed by frag-
ment length analysis with an ABI 3730 DNA analyzer and
GeneMapper software (v5). A single PCR fragment could either in-
dicate a homozygous variant or a pathogenic repeat expansion.
Subjects with a single PCR fragment were selected for RP-PCR,
and PCR products were analyzed with an ABI 3730 DNA
Analyzer and GeneMapper software. If the RP-PCR revealed a char-
acteristic stutter pattern, these individuals were screened using
Southern blotting techniques, as described previously (DeJesus-
Hernandez et al. 2011). A total of 7–10 µg of genomic DNAwas di-
gested with XbaI (Promega) and electrophoresed in a 0.8% agarose
gel. DNAwas then transferred to a positively charged nylonmem-
brane (Roche), cross-linked, and subsequently hybridized with a
digoxigenin (DIG)-labeled probe. Expansions were visualized
with anti-DIG antibody (Roche) and CDP-Star substrate (Roche)
on X-ray film.
Identifying IRRs
To test if a read fully consists of the repeat motif, we compared it to
the perfect repeat sequence that was the closest match under the
shift and reverse complement operations (e.g., a read originating
in a CAG repeat can consist of repetitions of either CAG, AGC,
GCA in the forward orientation or CTG, TGC, GCT in the reverse
orientation). To do the comparison, we defined the weighted puri-
ty (WP) score metric that assigns each matching base a score of 1,
each low-quality mismatch a score of 0.5 and each high-quality
mismatch a score of −1. After normalization of the sum of per-
base scores for the total read length, the WP ranges from −1 to
1. We defined IRRs as reads that achieve WP of 0.9 or higher
(Supplemental Methods).
Identifying off-target regions
Paired IRRs originating from expanded STRsmay align to other ge-
nomic locations, especially if the STR is short in the reference ge-
nome at the target location. We refer to the loci where IRRs may
misalign as off-target regions. Identifying off-target regions en-
ables us to reduce the search for IRRs to a few regions instead of
the whole genome. In order to obtain off-target regions for the
C9orf72 repeat, we searched through the 182 samples in cohort
one that had an expanded repeat according to the original RP-
PCR results to identify all the GGGGCC IRRs. The search was per-
formed through the whole genome for read pairs with a low map-
ping quality (MAPQ= 0) and aweighted purity score of at least 0.9.
The mapping positions of all identified IRRs were merged if they
were closer than 500 bp, and the resulting 29 loci that were present
in five or more samples were designated as off-target regions
(Supplemental Fig. 4) and were used to find additional reads
from the C9orf72 repeat expansion.
Repeat size estimation from IRRs
We assume that the probability of observing a read starting at a giv-
en base follows the Bernoulli distribution with the probability of
success parameter, π, equal to the ratio of the read depth to the
read length. Thus, starting positions of the reads occurring in a giv-
en region define a Bernoulli process, and the number of reads start-
ing in the region follows a binomial distribution. If r is the read
length, then one of the terminal bases of any IRRmust start at least
N− r bases away from the flanks of the repeat. The probability of
observing i such reads is
P(i,N − r) = N − r
i
( )
pi(1− p)N−r−i.
Becausewe have the estimates for i (the number of IRRs) and π (the
probability that there is a read starting at a given base), N (the re-
peat size) can be estimated by r + i/π. The confidence interval for
the repeat size is estimated by the parametric bootstrap method
(Rice 2007). The same procedure is used to obtain point estimates
and confidence intervals for repeat sizes from flanking reads. The
confidence interval is truncated according to the size of the longest
repeat sequence observed in a flanking read.
Repeat size determination from spanning reads
The reads spanning the repeat are identified from all the reads that
aligned within 1 kb of the target repeat region. Each of these reads
is tested for the presence of the repeat motif, after which the
flanking sequences of the repeat in the read is aligned to the
flanking sequences of the repeat in the reference. To be considered
spanning, a read must achieve a WP score of 0.9 across the repeat
sequence and its flanks. Furthermore, the flanking sequence
must have at most two fewer high-quality mismatches or four
fewer low-qualitymismatches compared to the sequence obtained
by extending the repeat. So, if the flanking sequence is similar
to the repeat motif, then more flanking sequence is required to
identify the end of the repeat and the beginning of the flanking
sequence.
Repeat genotyping
Genotype probabilities for repeats of size up to the read length
are calculated using a similar model as the one used for SNPs
(Li et al. 2009). Namely, P(G|R) = P(R|G) · P(G)/P(R) where the
genotype G is a tuple of repeat sizes with the number of entries
equal to the ploidy of the chromosome containing the repeat.
The probability P(R|G) is expressed in terms of the probabilities
P(ri|Hi) for individual reads ri and repeat alleles Hi as described (Li
et al. 2009).
If ri is a spanning read containingm repeat units, P(ri|Hi = n) =
π · f (m| p, n, s), where π is defined as above (“Repeat size estimation
from IRRs”). The frequency function f is defined by f(m|p, n, s)∼ p
(1− p)d, where m, n, s are non-negative integers bounded by
the maximum number of repeat units in a read which we denote
by u, p∈ (0, 1) corresponds to the proportion of molecules with
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repeat of the expected size, and d = |n−m| if |n−m| < s and d = s
otherwise. Note that f is defined similarly to the geometric fre-
quency function with parameter d representing the deviation
from n, the expected repeat size (which can be at most s). If ri
is a flanking or in-repeat read containing m repeat units,
P(ri|Hi = n) = p ·
∑u
i=m
f (i|p,n, s). In all our analyses, the parameters
p and swere set to 0.97 and 5. The values were chosen tomaximize
Mendelian consistency of genotype calls in Platinum Genome
pedigree samples (Eberle et al. 2017) on an unrelated set of repeats.
We use read-length-sized repeats as a stand-in for repeats lon-
ger than the read length. If only one allele is expanded,we estimate
the full size of the repeat as described above. If both alleles are ex-
panded, the size intervals are estimated similarly by assuming that
between 0 and 50% of in-repeat reads come from the short allele
and between 50% and 100% of in-repeat reads come from the
long allele.
Software availability
ExpansionHunter is written in C++, and its source code is included
in the Supplemental Materials. The software is licensed under
GPLv3.0, and the binaries, source code, and documentation are
also freely available at https://github.com/Illumina/Expansion
Hunter.
Data access
WGS for Coriell samples, WGS reads from C9orf72 repeat region
for Project MinE samples, and HTT repeat region for
Huntington’s disease samples from this study have been submit-
ted to the European Genome-phenome Archive (EGA; https://
www.ebi.ac.uk/ega/home) under accession numbers EGAS
00001002462, EGAS00001002598, and EGAS00001002593, re-
spectively. The following cell lines/DNA samples were obtained
from the NIGMS Human Genetic Cell Repository at the Coriell
Institute for Medical Research: NA04724, NA05446, NA05539,
NA05676, NA06477, NA06591, NA05470, NA05438, NA06075,
NA04567, NA05164, NA04648, NA05152, NA23378, NA23374,
NA23300, NA03986, NA03989, NA03990, NA03696, NA03759,
NA04034, NA03697, NA03132, NA03756, NA13716, NA13717,
NA03816, NA04079, NA14519, NA15850, NA15847, NA15848,
NA16197, NA16200, NA16202, NA16203, NA16205, NA16209,
NA16210, NA16212, NA16216, NA16213, NA16215, NA16214,
NA16227, NA16229, NA16228, NA16237, NA16243, NA16240,
NA16207, NA06895, NA04025, NA04926, NA05131, NA05185,
NA09145, NA09237, NA07063, NA07539, NA06890, NA06905,
NA07536, NA07540, NA07542, NA06910, NA06894, NA07541,
NA07175, NA06889, NA06893, NA06896, NA07538, NA07537,
NA06897, NA07174, NA06903, NA07543, NA06852, NA06891,
NA06907, NA06906, NA06892, NA06904, NA06968, NA07294,
NA09316, NA09317, NA09497, NA07730, CD00014, NA03200,
NA20235, NA20238, NA20237, NA20239, NA20242, NA20243,
NA20230, NA20232, NA20233, NA20234, NA20236, NA20231,
NA20240, NA20241, NA20244, NA07862, NA13509, NA13515,
CD00022, NA13507, NA13508, NA13510, NA13511, NA13512,
NA13513, NA13514, NA13503, NA13504, NA13505, NA13506,
NA06926, NA13536, NA13537, NA06151, NA23709.
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